aTyr Pharma

aTyr Pharma develops biologic therapeutics based on Physiocrine biology. The Company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. The Company's key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
2005
Size (employees)
58 (est)+6%
aTyr Pharma was founded in 2005 and is headquartered in San Diego, US

aTyr Pharma Office Locations

aTyr Pharma has an office in San Diego
San Diego, US (HQ)
3545 John Hopkins Ct
Show all (1)

aTyr Pharma Financials and Metrics

aTyr Pharma Financials

USD

Net income (Q3, 2017)

(11.2 m)

EBIT (Q3, 2017)

(10.8 m)

Market capitalization (22-Dec-2017)

91.2 m

Cash (30-Sep-2017)

29.8 m
aTyr Pharma's current market capitalization is $91.2 m.
USDFY, 2015FY, 2016

R&D expense

34.5 m42.8 m

General and administrative expense

13.1 m15.1 m

Operating expense total

47.6 m57.9 m

EBIT

(47.6 m)(57.9 m)
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

R&D expense

6.6 m7.5 m7.7 m12 m11.3 m10.4 m9.2 m8.4 m7.1 m

General and administrative expense

2.3 m3.4 m3.6 m4.1 m4.1 m3.5 m4 m3.5 m3.7 m

Operating expense total

8.9 m10.9 m11.3 m16.1 m15.4 m13.9 m13.2 m11.9 m10.8 m

Depreciation and amortization

552 k
USDFY, 2015FY, 2016

Cash

53 m38.4 m

Current Assets

98 m74.8 m

PP&E

1.8 m1.4 m

Total Assets

129.7 m80.5 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

54.5 m63.1 m60.1 m54.1 m43.2 m34.3 m28.9 m35.9 m29.8 m

Current Assets

55.2 m106.2 m111.4 m87.6 m85.9 m73.6 m63.8 m59.1 m92.2 m

PP&E

1.8 m2 m1.8 m1.8 m1.8 m1.6 m1.6 m2 m2.2 m

Total Assets

59.9 m153.1 m141.4 m115.1 m100.5 m85.9 m65.7 m61.5 m94.5 m
    USDFY, 2015FY, 2016

    Net Income

    (48 m)(57.9 m)

    Depreciation and Amortization

    869 k900 k

    Accounts Receivable

    (3.6 m)

    Accounts Payable

    3.9 m(932 k)
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

    Net Income

    (9.1 m)(11.1 m)(11.3 m)(16.1 m)(15.4 m)(13.8 m)(13.4 m)

    Accounts Payable

    3.2 m3 m1.6 m5.9 m4.7 m3.6 m1.2 m
      Y, 2017

      Financial Leverage

      1.3 x
      Show all financial metrics

      aTyr Pharma Market Value History

      aTyr Pharma's Web-traffic and Trends

      aTyr Pharma Online and Social Media Presence

      aTyr Pharma Company Life and Culture

      You may also be interested in